This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slid 9.62% to $2.63 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.30% to 3,790.38 and Dow Jones Industrial Average DJIA falling 0.46% to 30,630.17. Ocugen Inc. closed $15.02 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. ADVM remained unchanged, Ocular Therapeutix Inc. OCUL fell 4.23% to $4.30, and Kodiak Sciences Inc. KOD fell 0.44% to $9.10. Trading volume (4.4 M) remained 2.6 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2022.
(END) Dow Jones Newswires
July 14, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.